Literature DB >> 6549047

Expression of the amplified domain in human neuroblastoma cells.

R W Michitsch, K T Montgomery, P W Melera.   

Abstract

Screening of a partial cDNA library prepared from the human neuroblastoma cell line BE(2)-C with genomic DNA probes containing sequences representative of the amplified domain of that cell line allowed us to identify cloned transcripts from an active gene within the domain. The gene BE(2)-C-59 is amplified ca. 150-fold and encodes a 3.0- and a 1.5-kilobase RNA transcript, both of which are overproduced in BE(2)-C cells. A survey of a large variety of human tumor cell types indicated that this gene is amplified to varying degrees in all neuroblastoma cell lines and a retinoblastoma cell line that exhibit obvious cytological manifestations of DNA sequence amplification, i.e., homogeneously staining regions and double-minute chromosomes. The BE(2)-C-59 gene is not amplified, however, in other nonrelated tumor types, even those containing amplified DNA. Although the functional significance of this specific gene amplification in neuroblastoma cells remains unknown, an indication that it may relate to the malignant phenotype of these cells follows from the remainder of our data which show that the amplified BE(2)-C-59 gene shares partial homology with both the second and third exons, but not the first exon, of the human c-myc oncogene.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6549047      PMCID: PMC369067          DOI: 10.1128/mcb.4.11.2370-2380.1984

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.

Authors:  M Grunstein; D S Hogness
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

2.  Metaphase chromosome anomaly: association with drug resistance and cell-specific products.

Authors:  J L Biedler; B A Spengler
Journal:  Science       Date:  1976-01-16       Impact factor: 47.728

3.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

4.  Nature of Col E 1 plasmid replication in Escherichia coli in the presence of the chloramphenicol.

Authors:  D B Clewell
Journal:  J Bacteriol       Date:  1972-05       Impact factor: 3.490

5.  The development of resistance to methotrexate in a mouse melanoma cell line. I. Characterisation of the dihydrofolate reductases and chromosomes in sensitive and resistant cells.

Authors:  C J Bostock; E M Clark; N G Harding; P M Mounts; C Tyler-Smith; V van Heyningen; P M Walker
Journal:  Chromosoma       Date:  1979       Impact factor: 4.316

6.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

Authors:  J Fogh; W C Wright; J D Loveless
Journal:  J Natl Cancer Inst       Date:  1977-02       Impact factor: 13.506

7.  Double minute chromosomes and the homogeneously staining regions in chromosomes of a human neuroblastoma cell line.

Authors:  G Balaban-Malenbaum; F Gilbert
Journal:  Science       Date:  1977-11-18       Impact factor: 47.728

8.  Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions.

Authors:  L A Quinn; G E Moore; R T Morgan; L K Woods
Journal:  Cancer Res       Date:  1979-12       Impact factor: 12.701

9.  Stable mutants of mammalian cells that overproduce the first three enzymes of pyrimidine nucleotide biosynthesis.

Authors:  T D Kempe; E A Swyryd; M Bruist; G R Stark
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

10.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.

Authors:  M Schwab; K Alitalo; K H Klempnauer; H E Varmus; J M Bishop; F Gilbert; G Brodeur; M Goldstein; J Trent
Journal:  Nature       Date:  1983 Sep 15-21       Impact factor: 49.962

View more
  9 in total

1.  Nucleotide sequence of the 3' exon of the human N-myc gene.

Authors:  R W Michitsch; P W Melera
Journal:  Nucleic Acids Res       Date:  1985-04-11       Impact factor: 16.971

2.  Identification and characterization of the NMYC gene product in human neuroblastoma cells by monoclonal antibodies with defined specificities.

Authors:  N Ikegaki; J Bukovsky; R H Kennett
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Megabase-scale analysis of the origin of N-myc amplicons in human neuroblastomas.

Authors:  K Akiyama; N Kanda; M Yamada; K Tadokoro; T Matsunaga; Y Nishi
Journal:  Nucleic Acids Res       Date:  1994-01-25       Impact factor: 16.971

4.  Amplification units containing human N-myc and c-myc genes.

Authors:  K W Kinzler; B A Zehnbauer; G M Brodeur; R C Seeger; J M Trent; P S Meltzer; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

5.  Prognostic significance of the proliferative activity in neuroblastoma.

Authors:  P Rudolph; T Lappe; B Hero; F Berthold; R Parwaresch; D Harms; D Schmidt
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

6.  Human small-cell lung cancers show amplification and expression of the N-myc gene.

Authors:  M M Nau; B J Brooks; D N Carney; A F Gazdar; J F Battey; E A Sausville; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

7.  Differential amplification, assembly, and relocation of multiple DNA sequences in human neuroblastomas and neuroblastoma cell lines.

Authors:  Y Shiloh; J Shipley; G M Brodeur; G Bruns; B Korf; T Donlon; R R Schreck; R Seeger; K Sakai; S A Latt
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

8.  Nucleotide sequence of the coding region of the mouse N-myc gene.

Authors:  Y Taya; S Mizusawa; S Nishimura
Journal:  EMBO J       Date:  1986-06       Impact factor: 11.598

9.  Association of cytogenetic abnormalities in a neuroblastoma and fragile sites expression.

Authors:  P Vernole; C Concato; C Pianca; B Nicoletti; G Melino
Journal:  Br J Cancer       Date:  1988-09       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.